Works by Suryo Rahmanto, Aldwin

Results: 7
    1

    PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89389-9
    By:
    • Vidarsdottir, Linda;
    • Azimi, Alireza;
    • Das, Ishani;
    • Sigvaldadottir, Ingibjorg;
    • Suryo Rahmanto, Aldwin;
    • Petri, Andreas;
    • Kauppinen, Sakari;
    • Ingvar, Christian;
    • Jönsson, Göran;
    • Olsson, Håkan;
    • Frostvik Stolt, Marianne;
    • Tuominen, Rainer;
    • Sangfelt, Olle;
    • Pokrovskaja Tamm, Katja;
    • Hansson, Johan;
    • Grandér, Dan;
    • Egyházi Brage, Suzanne;
    • Johnsson, Per
    Publication type:
    Article
    2
    3

    CDK-mediated activation of the SCF<sup>FBXO</sup><sup>28</sup> ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer.

    Published in:
    EMBO Molecular Medicine, 2013, v. 5, n. 7, p. 999, doi. 10.1002/emmm.201202341
    By:
    • Cepeda, Diana;
    • Ng, Hwee‐Fang;
    • Sharifi, Hamid Reza;
    • Mahmoudi, Salah;
    • Cerrato, Vanessa Soto;
    • Fredlund, Erik;
    • Magnusson, Kristina;
    • Nilsson, Helén;
    • Malyukova, Alena;
    • Rantala, Juha;
    • Klevebring, Daniel;
    • Viñals, Francesc;
    • Bhaskaran, Nimesh;
    • Zakaria, Siti Mariam;
    • Rahmanto, Aldwin Suryo;
    • Grotegut, Stefan;
    • Nielsen, Michael Lund;
    • Szigyarto, Cristina Al‐Khalili;
    • Sun, Dahui;
    • Lerner, Mikael
    Publication type:
    Article
    4

    FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.

    Published in:
    EMBO Journal, 2016, v. 35, n. 20, p. 2192, doi. 10.15252/embj.201693889
    By:
    • Suryo Rahmanto, Aldwin;
    • Savov, Vasil;
    • Brunner, Andrä;
    • Bolin, Sara;
    • Weishaupt, Holger;
    • Malyukova, Alena;
    • Rosén, Gabriela;
    • Čančer, Matko;
    • Hutter, Sonja;
    • Sundström, Anders;
    • Kawauchi, Daisuke;
    • Jones, David TW;
    • Spruck, Charles;
    • Taylor, Michael D;
    • Cho, Yoon‐Jae;
    • Pfister, Stefan M;
    • Kool, Marcel;
    • Korshunov, Andrey;
    • Swartling, Fredrik J;
    • Sangfelt, Olle
    Publication type:
    Article
    5

    MEDU-26. LATENT SOX9-POSITIVE CELLS RESPONSIBLE FOR MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE.

    Published in:
    Neuro-Oncology, 2019, v. 21, p. ii108, doi. 10.1093/neuonc/noz036.185
    By:
    • Bolin, Sara;
    • Savov, Vasil;
    • Borgenvik, Anna;
    • Rosen, Gabriela;
    • Garancher, Alexandra;
    • Rahmanto, Aldwin Suryo;
    • Hutter, Sonja;
    • Mainwaring, Oliver;
    • Olausson, Karl Holmberg;
    • Rusert, Jessica;
    • Sundstrom, Anders;
    • Richardson, Stacey;
    • Fotaki, Grammatiki;
    • Hill, Rebecca;
    • Dubuc, Adrian;
    • Kalushkova, Antonia;
    • Remke, Marc;
    • Cancer, Matko;
    • Jernberg-Wiklund, Helena;
    • Ramaswamy, Vijay
    Publication type:
    Article
    6
    7